Filters
Bringing Better Health Within Reach: Hikma’s journey to become the Partner of choice in MENA
Insight, Corporate 29 April 2024
Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated
Press Release, Financial Results 25 April 2024
Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business
Press Release, Corporate 15 April 2024
Hikma’s Executive Vice Chairman and President of MENA Joins Rakuten Medical’s Board of Directors
Press Release, Corporate 07 March 2024
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results 22 February 2024
Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility
Press Release, Corporate 21 February 2024
Hikma launches Fentanyl Citrate Injection, USP, in a prefilled syringe in the US
Press Release, Product 20 February 2024
Hikma launches Alvimopan Capsules in the US
Press Release, Product 13 February 2024
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development 12 February 2024
Notice of preliminary results
Press Release, Financial Results 05 February 2024
Hikma announces US launch of COMBOGESIC® IV
Press Release, Product 05 February 2024
Hikma appoints Julie Hill, as Senior Vice President, Corporate Quality Compliance/Health and Safety
Press Release, Leadership 01 February 2024
Hikma Announces Agreement in Principle for Nationwide US Opioid Settlement Framework
Press Release, Corporate 01 February 2024
Activ Surgical, a Hikma Ventures portfolio company, completes the first international procedure using ActivSight™ Intell...
Press Release, Corporate 23 January 2024
Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology to t...
Press Release, Business Development 08 January 2024
You have viewed 15 of 424 results